Analyst: This Pharma Stock Could Triple

The brokerage firm also initiated coverage with an "outperform" rating

by Karee Venema

Published on Dec 7, 2018 at 10:35 AM

RBC initiated coverage on Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) with an "outperform" rating and $23 price target -- a 245% premium to last night's close. The analyst in coverage waxed optimistic over the long-term upside potential of the drugmaker's lead drug lenabasum, which is currently undergoing trials in patients with cystic fibrosis and systemic sclerosis.

In response, CRBP is trading up 5.8% at $7.05. The shares shot nearly 54% higher back on Sept. 20, on the back of a well-received licensing deal, but have since been stuck beneath a trendline connecting lower highs from early October. Today's pop has the shares aiming for a close in positive year-to-date territory, having entered 2018 trading at $7.10.

crbp stock daily price chart on dec 7

Analysts have remained upbeat on the shares, with 100% of those in coverage maintaining a "buy" or better rating. Plus, the average 12-month price target sits all the way up at $23.33.

Short sellers, on the other hand, have been actively targeting CRBP stock. Short interest on the pharma name is up almost 82% since the start of the year, to 14.12 million shares, and hit a record high 14.53 million shares in the Nov. 1 reporting period. The current number of shorted shares accounts for 26.3% of the equity's available float, or 15 times the average daily pace of trading.
SAGE Therapeutics Stock Hot Ahead of Earnings
The drug name is scheduled to report on Tuesday
Bear Signal Flashing for This Healthcare Stock Before Earnings
At least four analysts have issued price-target cuts on the stock this week
Signal Says This Retail Stock's on Sale
The shares pulled back this week on news of a Levi Strauss IPO
START YOUR DAY SMARTER.

Get Schaeffer's pre-market news bulletin every morning before the bell rings.
It's free to sign up.


Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


How to Predict Volatility Based on Earnings
A free tool can help traders bank big during the upcoming earnings season.
3 of Today's Worst Nasdaq Stocks
The stocks are sitting out today's rally in the broader equities market
2019 Rally Continues for Stock Market
The Nasdaq is eyeing its longest weekly win streak since 2016
How to Predict Volatility Based on Earnings
A free tool can help traders bank big during the upcoming earnings season.